On February 17, 2015, an objection to the disclosure statement with respect to a plan of reorganization or liquidation was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1130 and is described on the court’s official docket as follows:
Limited Objection with certificate of service filed by Creditors John W. Culclasure, Howell Allen Clinic, Donald Jones, M.D., Kenneth R. Lister, Kenneth R. Lister, M.D., P.C., Saint Thomas Outpatient Neurosurgical Center, Debra V. Schamberg, Specialty Surgery Center Re:  Corrected Disclosure Statement for Joint Chapter 11 Plan of New England Compounding Pharmacy, Inc. Dated December 3, 2014 filed by Creditor Committee Official Committee of Unsecured Creditors (Attachments: # 1 Exhibit A (Joint Chapter 11 Plan of New England Compounding Pharmacy, Inc.)) (Tardio, Chris)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.